Innovating.works Conecta tu I+D

Showing 1 to 20 of 29 results

GLIOMATCH: The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatia... FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA participó en un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 "Adult and paediatric malignant glioma (GBM and pHGG) remain among the most difficult-to-treat cancers with 5-year survival rates of <5% des...
2023-12-07 - 2028-12-31 | Financiado

FluoNeeD: Fluorinated Lipid Nanoparticles for Gene Delivery and Diagnostics FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA participó en un HORIZON EUROPE: HORIZON-MSCA-2022-PF-01 The formulation of drug nanocarriers has attracted increasing attention over the last decades. In particular, the possibility to combine the...
2023-04-28 - 2026-08-31 | Financiado

EMPOWER: European platforM to PromOte Wellbeing and HEalth in the woRkplace FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA participó en un H2020: H2020-SC1-BHC-2018-2020 EMPOWER is a multidisciplinary research and innovation effort aiming to developing, implementing, evaluating and disseminating the effective...
2019-12-06 - 2024-06-30 | Financiado

CLINGLIO: A Clinical Phase IIB trial with 2OHOA in patients with newly diagnosed malignant glioma. FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA participó en un H2020: H2020-SC1-2016-2017 "Glioma is a rare brain cancer with one of the highest mortality rates. It is considered an orphan disease due to its low prevalence (less t...
2017-11-27 - 2022-05-31 | Financiado

PAIN-Net: Molecule to man pain network FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA tramitó un H2020: H2020-MSCA-ITN-2016 Neuropathic pain affects 5% of the general population and 40% of patients with neurological diseases, and has a key role in the pathophysiol...
2016-08-31 - 2021-07-31 | Financiado

EU-GliaPhD: Training Research and Raising of Public Awareness in Cell Biology and Pathology of Neuroglia FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA participó en un H2020: H2020-MSCA-ITN-2016 The research in which the young scientists of the EU-GliaPhD consortium will be trained is centred on the role of neuron-glia interactions i...
2016-08-12 - 2021-06-30 | Financiado

EuroPOND: Data driven models for Progression Of Neurological Disease FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA participó en un H2020: H2020-PHC-2014-2015 EuroPOND will develop a data-driven statistical and computational modeling framework for neurological disease progression. This will enable...
2015-12-01 - 2020-12-31 | Financiado

DiaChemo: Point of care microfluidic device for quantification of chemotherapeutic drugs in small body fluid s... FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA participó en un H2020: H2020-PHC-2014-2015 The decision-making in chemotherapy nowadays depends on standard methods that are liquid chromatography (LC-MS/MS) followed by mass spectrom...
2015-04-13 - 2020-10-31 | Financiado

ATHLOS: Ageing Trajectories of Health Longitudinal Opportunities and Synergies FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA participó en un H2020: H2020-PHC-2014-2015 The objective of the ATHLOS Project is to achieve a better understanding of ageing by identifying patterns of healthy ageing pathways or tra...
2015-04-07 - 2020-04-30 | Financiado

THERAGLIO: Microbubble driven multimodal imaging and theranostics for gliomas FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA tramitó un FP7: Microbubbles (MBs) are used as contrast agent in ultrasound (US) imaging for a variety of tumours while little has been done for glioblastom...
Financiado

COURAGE IN EUROPE: COURAGE in Europe COllaborative Research on AGEing in Europe FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA tramitó un FP7: The European Commission has identified the challenge of population ageing as the most pressing policy issue in the 21st century. As European...
Financiado

PROPANE STUDY: PROBING THE ROLE OF SODIUM CHANNELS IN PAINFUL NEUROPATHIES FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA tramitó un FP7: Neuropathic pain is a frequent feature of peripheral neuropathy adversely impacting patients’ quality of life and increasing health care cos...
Financiado

MEET: Mitochondrial European Educational Training FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA participó en un FP7: The expanding diversification and specialization of knowledge and the growing complexity of contemporary research in translational research...
Financiado

TIRCON: Treat Iron Related Childhood Onset Neurodegeneration FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA participó en un FP7: Neurodegeneration with brain iron accumulation (NBIA) is a heterogeneous group of rare hereditary neurodegenerative disorders characterized...
Financiado

ACTIVE: Active Constraints Technologies for Ill defined or Volatile Environments FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA participó en un FP7: The ACTIVE project exploits ICT and other engineering methods and technologies for the design and development of an integrated redundant rob...
Financiado

NEUROPT: Non invasive imaging of brain function and disease by pulsed near infrared light FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA participó en un FP7: The proposal aims at the development and clinical validation of advanced non-invasive optical methodologies for in-vivo diagnosis, monitorin...
Financiado

LEUKOTREAT: Therapeutic challenge in Leukodystrophies Translational and ethical research towards clinical trial... FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA participó en un FP7: Leukodystrophies (LDs) are inherited rare neurodegenerative diseases of the white matter and its main component, the myelin, that are affect...
Financiado

EFACTS: European Friedreich s Ataxia Consortium for Translational Studies FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA participó en un FP7: EFACTS (the European Friedreich’s Ataxia Consortium for Translational Studies) assembles a body of expertise to adopt a translational resear...
Financiado

DESIRE: Development and Epilepsy Strategies for Innovative Research to improve diagnosis prevention and t... FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA participó en un FP7: DESIRE will focus on epileptogenic developmental disorders EDD, i.e. early onset epilepsies whose origin is closely related to developmental...
Financiado

FINCB